| dbo:assets
| |
| dbo:description
|
- American company (en)
- americká firma (cs)
- bedrijf in Verenigde Staten van Amerika (nl)
- enterprise (fr)
- شركة أمريكية (ar)
- US-amerikanisches Unternehmen (de)
- شركة ادويه (arz)
- Empresa farmacêutica (pt)
|
| dbo:equity
| |
| dbo:foundingYear
| |
| dbo:headquarter
| |
| dbo:industry
| |
| dbo:keyPerson
| |
| dbo:netIncome
| |
| dbo:numberOfEmployees
|
- 2525 (xsd:nonNegativeInteger)
|
| dbo:parentCompany
| |
| dbo:product
| |
| dbo:revenue
| |
| dbo:thumbnail
| |
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageWikiLink
| |
| dbp:assets
|
- (en)
- 1.8103E10 (dbd:usDollar)
|
| dbp:equity
|
- (en)
- 1.1651E10 (dbd:usDollar)
|
| dbp:founder
| |
| dbp:hqLocation
|
- (en)
- Boston, Massachusetts, U.S. (en)
|
| dbp:imageCaption
|
- Offices in New Haven, Connecticut (en)
|
| dbp:industry
| |
| dbp:keyPeople
|
- Ludwig N. Hantson (en)
- Leonard Bell (en)
|
| dbp:logo
| |
| dbp:name
|
- Alexion Pharmaceuticals, Inc. (en)
- Alexion Pharmaceuticals (en)
|
| dbp:netIncome
|
- (en)
- 6.03E8 (dbd:usDollar)
|
| dbp:numEmployees
| |
| dbp:parent
| |
| dbp:products
|
- (en)
- Eculizumab Ravulizumab Asfotase alfa Sebelipase alfa Andexanet alfa (en)
|
| dbp:revenue
|
- (en)
- 6.069E9 (dbd:usDollar)
|
| dbp:secCik
| |
| dbp:tradedAs
| |
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dct:subject
| |
| rdf:type
| |
| rdfs:label
|
- Alexion Pharmaceuticals (en)
- Alexion Pharmaceuticals (de)
- Alexion Pharmaceuticals (it)
- Alexion Pharmaceuticals (fr)
- Alexion Pharmaceuticals (nl)
- Alexion Pharmaceuticals (pt)
- Alexion Pharmaceuticals (uk)
- 瑞颂制药 (zh)
|
| owl:sameAs
| |
| skos:closeMatch
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Alexion Pharmaceuticals, Inc. (en)
|
| is dbo:subsidiary
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is dbp:subsid
of | |
| is foaf:primaryTopic
of | |
.jpg){kind=link}